rs1642785

Variant summary

Our verdict is Benign. The variant received -20 ACMG points: 0P and 20B. BP4_StrongBP6_Very_StrongBA1

The NM_001126118.2(TP53):​c.-123C>G variant causes a 5 prime UTR change involving the alteration of a non-conserved nucleotide. The variant allele was found at a frequency of 0.704 in 1,591,856 control chromosomes in the GnomAD database, including 397,543 homozygotes. In-silico tool predicts a benign outcome for this variant. Variant has been reported in ClinVar as Benign (★★).

Frequency

Genomes: 𝑓 0.66 ( 33859 hom., cov: 29)
Exomes 𝑓: 0.71 ( 363684 hom. )

Consequence

TP53
NM_001126118.2 5_prime_UTR

Scores

2

Clinical Significance

Benign criteria provided, multiple submitters, no conflicts B:14

Conservation

PhyloP100: 0.128

Publications

90 publications found
Variant links:
Genes affected
TP53 (HGNC:11998): (tumor protein p53) This gene encodes a tumor suppressor protein containing transcriptional activation, DNA binding, and oligomerization domains. The encoded protein responds to diverse cellular stresses to regulate expression of target genes, thereby inducing cell cycle arrest, apoptosis, senescence, DNA repair, or changes in metabolism. Mutations in this gene are associated with a variety of human cancers, including hereditary cancers such as Li-Fraumeni syndrome. Alternative splicing of this gene and the use of alternate promoters result in multiple transcript variants and isoforms. Additional isoforms have also been shown to result from the use of alternate translation initiation codons from identical transcript variants (PMIDs: 12032546, 20937277). [provided by RefSeq, Dec 2016]
TP53 Gene-Disease associations (from GenCC):
  • breast cancer
    Inheritance: AD Classification: DEFINITIVE Submitted by: Ambry Genetics
  • Li-Fraumeni syndrome
    Inheritance: AD Classification: DEFINITIVE, STRONG, SUPPORTIVE Submitted by: ClinGen, G2P, Labcorp Genetics (formerly Invitae), Orphanet
  • Li-Fraumeni syndrome 1
    Inheritance: AD Classification: DEFINITIVE, STRONG Submitted by: Ambry Genetics, Genomics England PanelApp
  • adrenocortical carcinoma, hereditary
    Inheritance: AD Classification: STRONG Submitted by: Ambry Genetics
  • sarcoma
    Inheritance: AD Classification: STRONG Submitted by: Genomics England PanelApp
  • bone marrow failure syndrome 5
    Inheritance: AD Classification: MODERATE Submitted by: Ambry Genetics
  • colorectal cancer
    Inheritance: AD Classification: MODERATE Submitted by: Ambry Genetics
  • choroid plexus carcinoma
    Inheritance: AD Classification: SUPPORTIVE Submitted by: Orphanet

Genome browser will be placed here

ACMG classification

Classification was made for transcript

Our verdict: Benign. The variant received -20 ACMG points.

BP4
Computational evidence support a benign effect (BayesDel_noAF=-0.83).
BP6
Variant 17-7676483-G-C is Benign according to our data. Variant chr17-7676483-G-C is described in ClinVar as Benign. ClinVar VariationId is 137691.Status of the report is criteria_provided_multiple_submitters_no_conflicts, 2 stars.
BA1
GnomAd4 highest subpopulation (NFE) allele frequency at 95% confidence interval = 0.734 is higher than 0.05.

Variant Effect in Transcripts

ACMG analysis was done for transcript: NM_001126118.2. You can select a different transcript below to see updated ACMG assignments.

RefSeq Transcripts

Sel.
GeneTranscriptTagsHGVScHGVSpEffectExon RankProteinUniProt
TP53
NM_000546.6
MANE Select
c.74+38C>G
intron
N/ANP_000537.3
TP53
NM_001126118.2
c.-123C>G
5_prime_UTR
Exon 2 of 10NP_001119590.1H2EHT1
TP53
NM_001126112.3
c.74+38C>G
intron
N/ANP_001119584.1K7PPA8

Ensembl Transcripts

Sel.
GeneTranscriptTagsHGVScHGVSpEffectExon RankProteinUniProt
TP53
ENST00000610292.4
TSL:1
c.-123C>G
5_prime_UTR
Exon 2 of 10ENSP00000478219.1P04637-4
TP53
ENST00000269305.9
TSL:1 MANE Select
c.74+38C>G
intron
N/AENSP00000269305.4P04637-1
TP53
ENST00000445888.6
TSL:1
c.74+38C>G
intron
N/AENSP00000391478.2P04637-1

Frequencies

GnomAD3 genomes
AF:
0.660
AC:
100053
AN:
151570
Hom.:
33859
Cov.:
29
show subpopulations
Gnomad AFR
AF:
0.515
Gnomad AMI
AF:
0.669
Gnomad AMR
AF:
0.710
Gnomad ASJ
AF:
0.715
Gnomad EAS
AF:
0.574
Gnomad SAS
AF:
0.519
Gnomad FIN
AF:
0.726
Gnomad MID
AF:
0.639
Gnomad NFE
AF:
0.740
Gnomad OTH
AF:
0.685
GnomAD2 exomes
AF:
0.673
AC:
166700
AN:
247548
AF XY:
0.667
show subpopulations
Gnomad AFR exome
AF:
0.516
Gnomad AMR exome
AF:
0.718
Gnomad ASJ exome
AF:
0.710
Gnomad EAS exome
AF:
0.571
Gnomad FIN exome
AF:
0.719
Gnomad NFE exome
AF:
0.732
Gnomad OTH exome
AF:
0.694
GnomAD4 exome
AF:
0.708
AC:
1020340
AN:
1440172
Hom.:
363684
Cov.:
43
AF XY:
0.703
AC XY:
503952
AN XY:
717364
show subpopulations
African (AFR)
AF:
0.503
AC:
16760
AN:
33294
American (AMR)
AF:
0.719
AC:
32091
AN:
44644
Ashkenazi Jewish (ASJ)
AF:
0.712
AC:
18519
AN:
26012
East Asian (EAS)
AF:
0.604
AC:
23952
AN:
39624
South Asian (SAS)
AF:
0.504
AC:
43370
AN:
86008
European-Finnish (FIN)
AF:
0.723
AC:
38374
AN:
53088
Middle Eastern (MID)
AF:
0.603
AC:
3455
AN:
5728
European-Non Finnish (NFE)
AF:
0.735
AC:
802203
AN:
1092010
Other (OTH)
AF:
0.696
AC:
41616
AN:
59764
Allele Balance Distribution
Red line indicates average allele balance
Average allele balance: 0.499
Heterozygous variant carriers
0
17315
34631
51946
69262
86577
0.00
0.20
0.40
0.60
0.80
0.95
Allele balance

Age Distribution

Exome Het
Exome Hom
Variant carriers
0
19584
39168
58752
78336
97920
<30
30-35
35-40
40-45
45-50
50-55
55-60
60-65
65-70
70-75
75-80
>80
Age
GnomAD4 genome
AF:
0.660
AC:
100079
AN:
151684
Hom.:
33859
Cov.:
29
AF XY:
0.656
AC XY:
48622
AN XY:
74104
show subpopulations
African (AFR)
AF:
0.515
AC:
21280
AN:
41348
American (AMR)
AF:
0.711
AC:
10807
AN:
15208
Ashkenazi Jewish (ASJ)
AF:
0.715
AC:
2482
AN:
3470
East Asian (EAS)
AF:
0.573
AC:
2931
AN:
5116
South Asian (SAS)
AF:
0.521
AC:
2507
AN:
4812
European-Finnish (FIN)
AF:
0.726
AC:
7622
AN:
10498
Middle Eastern (MID)
AF:
0.633
AC:
186
AN:
294
European-Non Finnish (NFE)
AF:
0.740
AC:
50235
AN:
67928
Other (OTH)
AF:
0.676
AC:
1420
AN:
2100
Allele Balance Distribution
Red line indicates average allele balance
Average allele balance: 0.499
Heterozygous variant carriers
0
1660
3320
4979
6639
8299
0.00
0.20
0.40
0.60
0.80
0.95
Allele balance

Age Distribution

Genome Het
Genome Hom
Variant carriers
0
792
1584
2376
3168
3960
<30
30-35
35-40
40-45
45-50
50-55
55-60
60-65
65-70
70-75
75-80
>80
Age
Alfa
AF:
0.688
Hom.:
6716
Bravo
AF:
0.656
Asia WGS
AF:
0.526
AC:
1831
AN:
3478

ClinVar

ClinVar submissions
Significance:Benign
Revision:criteria provided, multiple submitters, no conflicts
View on ClinVar
Pathogenic
VUS
Benign
Condition
-
-
5
not specified (5)
-
-
3
Hereditary cancer-predisposing syndrome (3)
-
-
2
Li-Fraumeni syndrome 1 (2)
-
-
2
not provided (2)
-
-
1
Hereditary breast ovarian cancer syndrome (1)
-
-
1
Li-Fraumeni syndrome (1)

Computational scores

Source: dbNSFP v4.9

Name
Calibrated prediction
Score
Prediction
BayesDel_noAF
Benign
-0.83
CADD
Benign
1.2
DANN
Benign
0.57
PhyloP100
0.13
PromoterAI
-0.070
Neutral
RBP_binding_hub_radar
0.0
RBP_regulation_power_radar
1.0
Mutation Taster
=100/0
polymorphism (auto)

Splicing

Name
Calibrated prediction
Score
Prediction
SpliceAI score (max)
0.0
Details are displayed if max score is > 0.2

Find out detailed SpliceAI scores and Pangolin per-transcript scores at spliceailookup.broadinstitute.org

Publications

Other links and lift over

dbSNP: rs1642785; hg19: chr17-7579801; COSMIC: COSV52668860; COSMIC: COSV52668860; API